Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Amylin”

96 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 96 results

Not applicableStudy completedNCT00622323
What this trial is testing

Post Marketing Surveillance Study of Byetta ™ (Exenatide) Use Among Filipino Patients

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 41
Not applicableUnknownNCT04243629
What this trial is testing

Co-administration of Pramlintide and Insulin Via an Automated Dual-hormone Artificial Pancreas System in Adults With Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1Type 1 DiabetesPostprandial Hyperglycemia
McGill University 26
Post-approval studies (Phase 4)Study completedNCT00240253
What this trial is testing

A Study Evaluating the Efficacy and Safety of Adding Symlin® to Lantus® (Insulin Glargine) in Subjects With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 200
Post-approval studies (Phase 4)Study completedNCT00870194
What this trial is testing

A Comparison of Adding Exenatide With Switching to Exenatide in Patients With Type 2 Diabetes Experiencing Inadequate Glycemic Control With Sitagliptin Plus Metformin

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 255
Large-scale testing (Phase 3)Study completedNCT00641056
What this trial is testing

Efficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Treated With Metformin Alone or in Combination With Sulfonylurea (DURATION - 3)

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 467
Testing effectiveness (Phase 2)Study completedNCT00500370
What this trial is testing

A Pilot Study of Effects of Exenatide on Body Weight in Non-Diabetic, Obese Patients

Who this might be right for
Obesity
AstraZeneca 163
Early research (Phase 1)Study completedNCT00612794
What this trial is testing

Examine Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Exenatide Once Weekly in Japanese Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
AstraZeneca 30
Testing effectiveness (Phase 2)Study completedNCT06662539
What this trial is testing

Once-weekly Petrelintide Versus Placebo for Obesity or Overweight With Co-morbidities

Who this might be right for
Obesity
Zealand Pharma 493
Testing effectiveness (Phase 2)Study completedNCT01104701
What this trial is testing

Examine the Efficacy, Safety and Tolerability, and Pharmacokinetics of Exenatide Once Monthly Suspension

Who this might be right for
Type 2 Diabetes
AstraZeneca 121
Large-scale testing (Phase 3)Study completedNCT00935532
What this trial is testing

Study to Evaluate the Efficacy and Safety of Exenatide Once-Weekly Injection Compared to Once-Daily Insulin in Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 427
Testing effectiveness (Phase 2)Study completedNCT00402077
What this trial is testing

Examine the Safety, Tolerability, and Body Weight Effect of Pramlintide Alone and in Combination With Oral Antiobesity Agents in Overweight and Obese Subjects

Who this might be right for
OverweightObesity
AstraZeneca 258
Not applicableLooking for participantsNCT03481283
What this trial is testing

A Causative Role for Amylin in Diabetic Peripheral Neuropathy

Who this might be right for
Type2 DiabetesPeripheral Neuropathy
Zabeen Mahuwala, MD 40
Large-scale testing (Phase 3)UnknownNCT01137695
What this trial is testing

Efficacy Study of High Dose Symlin to Treat Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Cheryl Rosenfeld, DO 40
Testing effectiveness (Phase 2)Study completedNCT00085969
What this trial is testing

Effect of Exenatide Monotherapy on Glucose Control in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
AstraZeneca 99
Large-scale testing (Phase 3)Study completedNCT00753896
What this trial is testing

Safety of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus Treated With Thiazolidinedione Alone or Thiazolidinedione in Combination With Metformin

Who this might be right for
Type 2 Diabetes
AstraZeneca 134
Testing effectiveness (Phase 2)Study completedNCT00444561
What this trial is testing

Exploratory Study to Evaluate Various Pharmacodynamic Effects of Subcutaneously Infused or Injected Pramlintide in Obese Subjects

Who this might be right for
OverweightObesity
AstraZeneca 184
Testing effectiveness (Phase 2)Looking for participantsNCT07575932
What this trial is testing

PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1)

Who this might be right for
OverweightObesityOverweight and/or Obesity+5 more
Pfizer 872
Testing effectiveness (Phase 2)Study completedNCT00099333
What this trial is testing

Study of the Safety of Substituting Exenatide for Insulin in Patients Using Insulin and Oral Antidiabetic Agents

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 49
Early research (Phase 1)Study completedNCT00672399
What this trial is testing

Electrophysiological Effects of a Single 10 μg Dose of Exenatide on the 12-Lead Electrocardiogram QT Interval in Healthy Subjects

Who this might be right for
Healthy Subjects
AstraZeneca 70
Large-scale testing (Phase 3)Study completedNCT00206258
What this trial is testing

The Role of Amylin and Glucagon in T1DM

Who this might be right for
Type 1 Diabetes
Baylor College of Medicine 30
Load More Results